07:00 , Oct 14, 2013 |  BC Week In Review  |  Clinical News

Grazax grass pollen Allergy Immunotherapy Tablet regulatory update

FDA postponed a Nov. 5-6 meeting of the Allergenic Products Advisory Committee that was scheduled to discuss 2 grass pollen allergy products due to the shutdown of the federal government. The agency said it postponed...
07:00 , Oct 14, 2013 |  BC Week In Review  |  Clinical News

Oralair regulatory update

FDA postponed a Nov. 5-6 meeting of the Allergenic Products Advisory Committee that was scheduled to discuss 2 grass pollen allergy products due to the shutdown of the federal government. The agency said it postponed...
00:31 , Oct 9, 2013 |  BC Extra  |  Company News

FDA postpones allergenic advisory committee meeting

FDA postponed a Nov. 5-6 meeting of the Allergenic Products Advisory Committee that was scheduled to discuss two grass pollen allergy products due to the shutdown of the federal government. The agency said it postponed...
07:00 , Aug 8, 2005 |  BioCentury  |  Emerging Company Profile

Curalogic: Edible allergens

Traditional immunotherapy for allergies consists of subcutaneous injections of natural allergens - given as often as several times a week - that cause the immune system to become gradually desensitized over three to five years....
08:00 , Nov 4, 2002 |  BioCentury  |  Regulation

Oversight shift

Oversight shift...
08:00 , Oct 29, 2002 |  BC Extra  |  Top Story

Future CDER, CBER jurisdictions

An FDA working group has developed a list of the types of products that will be transferred to the Center for Drug Evaluation and Research from the Center for Biologics Evaluation and Research as part...
07:00 , Aug 24, 1998 |  BC Week In Review  |  Company News

Allergenics board of directors update

Allergenics Inc., Cincinnati, Ohio   Business: Autoimmune/Inflammation, Cancer, Infectious diseases   Appointed: Clint Dederick, president; Patrick Latterell, general partner at Venrock Associates; Vince Paglino, VP of business development at Senmed Medical Ventures; Jim Philipkosky, general...
07:00 , May 26, 1998 |  BC Week In Review  |  Company News

Allergenics, Chiron deal

CHIR will evaluate and help develop Allergenics' orally delivered vaccines for tetanus and H. pylori. Depending on the results of trials, the companies will discuss a future collaboration including manufacturing and marketing rights to the...